Heerspink, H. J. L., Sjöström, C. D., Jongs, N., Chertow, G. M., Kosiborod, M., Hou, F. F., . . . Wheeler, D. C. (2021). Effects of dapagliflozin on mortality in patients with chronic kidney disease: A pre-specified analysis from the DAPA-CKD randomized controlled trial. Eur Heart J.
Citación estilo ChicagoHeerspink, Hiddo J L., et al. "Effects of Dapagliflozin On Mortality in Patients With Chronic Kidney Disease: A Pre-specified Analysis From the DAPA-CKD Randomized Controlled Trial." Eur Heart J 2021.
Cita MLAHeerspink, Hiddo J L., et al. "Effects of Dapagliflozin On Mortality in Patients With Chronic Kidney Disease: A Pre-specified Analysis From the DAPA-CKD Randomized Controlled Trial." Eur Heart J 2021.
Precaución: Estas citas no son 100% exactas.